Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Chemokines, a novel target for personalised treatment in major depressive disorders
1United Arab Emirates University, College of Medicine and Health Sciences, Department of Psychiatry, Al Ain, Abu Dhabi, United Arab Emirates; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Psychological Medicine, Centre for Affective Disorders, London, UK.
No abstract available in PubMed .
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
06:15A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
Published on: July 15, 2025
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Depressive Disorders: MDD and Dysthymia
Targeted Cancer Therapies
There are several types of targeted therapies against...